Kristen Harrington-Smith

Kristen Harrington-Smith

Director/Board Member at EFFECTOR THERAPEUTICS, INC.

Net worth: 733 000 $ as of 2024-01-30

51 year
Health Technology
Consumer Services

Profile

Kristen Harrington-Smith is currently an Independent Director at eFFECTOR Therapeutics, Inc. and the Chief Commercial Officer at ADC Therapeutics SA. Prior to her current roles, she was the Chief Commercial Officer & Senior Vice President at ImmunoGen, Inc. from 2021 to 2022 and the US Commercial Head-Hematology at Novartis Pharmaceuticals from 2020 to 2021.
She received her undergraduate degree from Williams College and her MBA from Kenan-Flagler Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2022-11-14 25,000 ( 0.01% ) 733 000 $ 2024-01-30
2024-04-17 0 ( -.--% ) - $ 2024-04-29

Kristen Harrington-Smith active positions

CompaniesPositionStart
EFFECTOR THERAPEUTICS, INC. Director/Board Member 2022-02-14
ADC THERAPEUTICS SA Corporate Officer/Principal 2022-11-16
All active positions of Kristen Harrington-Smith

Former positions of Kristen Harrington-Smith

CompaniesPositionEnd
IMMUNOGEN, INC. Corporate Officer/Principal 2022-11-15
Corporate Officer/Principal 2021-10-31
See the detail of Kristen Harrington-Smith's experience

Training of Kristen Harrington-Smith

Williams College Undergraduate Degree
Kenan-Flagler Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Kristen Harrington-Smith's experience

Connections

42

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
IMMUNOGEN, INC.

Health Technology

EFFECTOR THERAPEUTICS, INC.

Health Technology

ADC THERAPEUTICS SA

Health Technology

Private companies1

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. Kristen Harrington-Smith
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW